【NASDAQ-listed company Anixa Biosciences' board approves the purchase of Bitcoin as a reserve asset】Golden Finance reports that the board of NASDAQ-listed company Anixa Biosciences has approved the purchase of Bitcoin as a reserve asset. The company also reiterated its ongoing stock repurchase plan. The company's CEO, Amit Kumar, stated that the decision regarding Bitcoin is another method of prudent financial management that can achieve higher shareholder value. It is reported that Anixa Biosciences is a biotechnology company focused on the treatment and prevention of cancer.